ARTICLE | Management Tracks
Robertson becomes Opthea’s first CCO
Plus: 4D Pharma, NeuShen, Mind, PolyPid and Biosion
January 3, 2022 10:53 PM UTC
Australian retinal disease company Opthea Ltd. (ASX:OPT; NASDAQ:OPT) hired Judith Robertson as its first CCO. Robertson previously held CCO positions at Eleusis Ltd. and Aerie Pharmaceuticals Inc. (NASDAQ:AERI), and had been on Opthea’s board since June — she relinquished the position concurrent with her new appointment.
4D pharma plc (LSE:DDDD; NASDAQ:LBPS) hired John Doyle as CFO. Doyle was previously CFO at Chiasma Inc. (NASDAQ:CHMA) and VP of finance and investor relations at Verastem Inc. (NASDAQ:VSTM). 4D is developing live biotherapeutics, a class of drug derived from the microbiome. ...